[1] Holguin JA,MargetisJL,Narayan A,et al.Vascular Cognitive Impairment After Mild Stroke:Connectomic Insights,Neuroimaging,and Knowledge Translation[J].Front Neurosci,2022,16:905979. [2] Rundek T,Tolea M,Ariko T,et al.Vascular Cognitive Impairment (VCI)[J].Neurotherapeutics,2022,19(1):68~88. [3] Islam MR,Kaurani L,Berulava T,et al.A microRNA signature that correlates with cognition and is a target against cognitive decline[J].EMBO Mol Med,2021,13(11):e13659. [4] Wei ZD,Shetty AK.Can mild cognitive impairment and Alzheimer's disease be diagnosed by monitoring a miRNA triad in the blood?[J].Aging Cell,2022,21(6):e13627. [5] Liu XM,Ma L,Schekman R.Selective sorting of microRNAs into exosomes by phase-separated YBX1 condensates[J].Elife,2021,10:e71982. [6] 赵维纳,孙文强,贺梦菲,等.血浆外泌体miR-29c在血管性认知障碍患者中的表达及意义[J].中国老年学杂志,2020,40(8):1668~1670. [7] Carini G,Musazzi L,Bolzetta F,et al.The Potential Role of miRNAs in Cognitive Frailty[J].Front Aging Neurosci,2021,13:763110. [8] Skrobot OA,Black SE,Chen C,et al.血管性认知损害诊断的进一步规范化:血管性认知损害分类共识研究组指南[J].国际脑血管病杂志,2018,26(4):241~250. [9] Jia X,Wang Z,Huang F,et al.A comparison of the Mini-Mental State Examination (MMSE) with the Montreal Cognitive Assessment (MoCA) for mild cognitive impairment screening in Chinese middle-aged and older population:a cross-sectional study[J].BMC Psychiatry,2021,21(1):485. [10] 廖子蔚,程利萍,张苗苗.ApoB/LDL比值与血管性认知障碍的相关性[J].中国老年学杂志,2022,42(4):878~881. [11] Zhai W,Zhao M,Zhang G,et al.MicroRNA-Based Diagnosis and Therapeutics for Vascular Cognitive Impairment and Dementia[J].Front Neurol,2022,13:895316. [12] Azimi T,Paryan M,Mondanizadeh M,et al.Pap Smear miR-92a-5p and miR-155-5p as potential diagnostic biomarkers of squamous intraepithelial cervical cancer[J].Asian Pac J Cancer Prev,2021,22(4):1271~1277. [13] Wang YP,Liu J,Liu D,et al.MiR-532-5p acts as a tumor suppressor and inhibits glioma cell proliferation by targeting CSF1[J].Eur Rev Med Pharmacol Sci,2020,24(13):7206. [14] Yao Q,Zhu B.Effects of miR-532-5p on human brain microvascular endothelial cells damage induced by ox-LDL via down-regulating CLIC4 expression[J].Pak J Pharm Sci,2020,33(3(Special)):1435~1441. [15] Mu J,Cheng X,Zhong S,et al.Neuroprotective effects of miR-532-5p against ischemic stroke[J].Metab Brain Dis,2020,35(5):753~763. [16] Dakterzada F,Targa A,Benítez ID,et al.Identification and validation of endogenous control miRNAs in plasma samples for normalization of qPCR data for Alzheimer's disease[J].Alzheimers Res Ther,2020,12(1):163. [17] Amidfar M,de Oliveira J,Kucharska E,et al.The role of CREB and BDNF in neurobiology and treatment of Alzheimer's disease[J].Life Sci,2020,257:118020. [18] Wang CS,Kavalali ET,MonteggiaLM.BDNF signaling in context:From synaptic regulation to psychiatric disorders[J].Cell,2022,185(1):62~76. [19] Katsipis G,Tzekaki EE,Tsolaki M,et al.Salivary GFAP as a potential biomarker for diagnosis of mild cognitive impairment and Alzheimer's disease and its correlation with neuroinflammation and apoptosis[J].J Neuroimmunol,2021,361:577744. [20] Pereira JB,Janelidze S,Smith R,et al.Plasma GFAP is an early marker of amyloid-β but not tau pathology in Alzheimer's disease[J].Brain,2021 Dec 16;144(11):3505~3516. [21] Luzzi S,Papiri G,Viticchi G,et al.Association between homocysteine levels and cognitive profile in Alzheimer's Disease[J].J Clin Neurosci,2021,94:250~256. [22] Luzzi S,Papiri G,Viticchi G,et al.Association between homocysteine levels and cognitive profile in Alzheimer's Disease[J].J Clin Neurosci.2021,Dec,94:250~256. [23] 潘庭荣,黄梅,潘丹丹,等.脑卒中患者Hcy,GFAP,BDNF和hs-CRP水平与血管性认知障碍相关性研究[J].东南大学学报(医学版),37(4):648~652. |